Загрузка...
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...
Сохранить в:
| Опубликовано в: : | Neurobiol Stress |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6804800/ https://ncbi.nlm.nih.gov/pubmed/31649968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100196 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|